Treatment of Balo's concentric sclerosis with immunosuppressive drugs followed by multimodality evoked potentials and MRI.
D000293:Adolescent; D001379:Azathioprine / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003711:Demyelinating Diseases / Q000188:drug therapy*; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000188:drug therapy* / Q000503:physiopathology; D005071:Evoked Potentials / Q000187:drug effects*; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D013979:Tibial Nerve / Q000503:physiopathology; D013997:Time Factors
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001379:Azathioprine